/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S.
WIRE SERVICES/
WINNIPEG,
July 3, 2018 /CNW/
- DELTA 9 CANNABIS INC. (TSXV: NINE) ("Delta 9" or the
"Company") is pleased to announce the planned locations for its
first cannabis retail stores. Delta 9 intends to open two stores in
Winnipeg, one in Brandon and one in Thompson before the end of the year. At least
one of the Winnipeg stores is
expected to be open on October 17,
2018, which is the date that has been announced as the first
day for legal retail sales of cannabis. The Company's online sales
portal will also be operating on that date.
Delta 9 CEO John Arbuthnot
explained why the Company is opening stores in smaller cities and
towns. "We share the provincial
government's desire to provide access to
recreational cannabis in different regions of the province. As a
Manitoba-based company, we are
very conscious of the fact we bear an additional responsibility to
smaller Manitoba communities.
Geographic distribution of cannabis stores is an important factor
in moving cannabis sales away from the black market and we in turn
have made that one of our key goals for this year."
Delta 9 has not yet released the addresses or exact
locations of their upcoming retail outlets, but Arbuthnot says all
are located in tier one commercial real estate spaces. All
locations are in areas suited to commercial and retail activity,
and all are in areas with heavy vehicular and pedestrian traffic.
"We're very happy with the locations
we've acquired thus far," Arbuthnot says.
"I expect all of these sites will perform very well."
Construction has already begun on one location in
Winnipeg, where the 3,000 foot
space has been gutted to the bare studs in preparation for the
design of a Delta 9 "Signature Store". A
second location is already close to being ready for retail sales,
while the outlets in Thompson and
Brandon are still in the design
phase. Arbuthnot says the number of stores to be opened in 2019
will depend on the retail allotments issued by the Manitoba government to existing and new
retailers.
"We're confident we can build out to the maximum allotment
of retail outlets next year, whatever number that may be,"
Arbuthnot said. "We have the capital set aside, our branding and
design elements are in place, and we're
excited to start moving into the era of post-prohibition cannabis
sales."
Delta 9 currently has one clinic operating in Winnipeg. The clinic is dedicated to helping
cannabis patients get a prescription if needed. The clinic will
remain open and functioning until patients in Canada have better access to doctors who are
educated in cannabis treatment protocols.
The Company is also ramping up production in order to meet
its Agreement to supply at least 2.3 million grams to Manitoba
Liquor and Lotteries over the first year of operations, and to meet
its other commitments across Canada and in Germany.
On Behalf of the Board of Directors
John Arbuthnot, CEO
About Delta 9 Cannabis Inc.
Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is
a licensed producer of medical marijuana pursuant to the ACMPR and
operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9's shares
trade on the TSX Venture Exchange under the symbol
"NINE".
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Disclaimer for Forward-Looking
Information
Certain statements in this release are
forward-looking statements, which reflect the expectations of
management regarding the Company's future business plans and other
matters. Forward-looking statements consist of statements that are
not purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future. Forward
looking statements in this news release include statements relating
to Delta 9's plans for opening retail stores to sell cannabis. Such
statements are subject to risks and uncertainties that may cause
actual results, performance or developments to differ materially
from those contained in the statements, including that Delta 9's
currently contemplated expansion and development plans may cease or
otherwise change, Delta 9's production of cannabis may be lower
than expected, Delta 9 may not obtain the required approvals from
Health Canada, demand for Delta 9's products may be lower than
anticipated, Delta 9's cost to produce its grow pods may be higher
than expected and all other risk factors set forth in the annual
information form of Delta 9 dated May 31,
2018 which has been filed on SEDAR. No assurance can be
given that any of the events anticipated by the forward-looking
statements will occur or, if they do occur, what benefits the
Company will obtain from them. Readers are urged to consider these
factors carefully in evaluating the forward-looking statements
contained in this news release and are cautioned not to place undue
reliance on such forward-looking statements, which are qualified in
their entirety by these cautionary statements. These
forward-looking statements are made as of the date hereof and the
Company disclaims any intent or obligation to update publicly any
forward-looking statements, whether as a result of new information,
future events or results or otherwise, except as required by
applicable securities laws.
SOURCE Delta 9 Cannabis Inc.